Here are six recalls reported by Becker’s Hospital Review in the last two months:
1. 2 injectable drugs recalled over microbial growth
Heritage Pharmaceuticals issued a recall for two injectable drugs after microbial growth was detected in an unreleased lot of both products, according to a recall notice on the FDA’s website.
2. FDA recalls 3 blood test analyzers
The FDA is warning hospitals, laboratories and clinicians about a Class 1 recall of three hematology analyzers manufactured by Beckman Coulter after several reports of inaccuracies related to blood platelet counts.
3. Losartan recall expands — again
Vivimed Life Sciences issued a recall for 19 lots of losartan potassium tablets after detecting a potentially carcinogenic impurity.
4. Eye disease treatment recalled after 2 adverse event reports
AmEx Pharmacy is recalling one lot of Bevacizumab injectable, used to treat macular degeneration and diabetic retinopathy, due to a defective delivery system that has resulted in two adverse events.
5. Mislabeled fentanyl patches recalled
Alvogen, a pharmaceutical company based in New Jersey, is recalling two lots of its transdermal fentanyl patches due to faulty product labeling.
6. Torrent Pharmaceuticals recalls 104 more lots of blood pressure drug
Torrent Pharmaceuticals is recalling an additional 104 lots of losartan blood pressure tablets.
More articles on pharmacy:
Viewpoint: The $2.1M drug price record won’t last long
J&J to cut 61 jobs in New Jersey
Mallinckrodt to spin off generics unit
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
